Products Antibodies Monoclonal Antibodies [KD Validated] Anti-PCSK9 (Proprotein Convertase 9) Monoclonal Antibody for WB, ELISA - Q8NBP7
[KD Validated] Anti-PCSK9 (Proprotein Convertase 9) Monoclonal Antibody for WB, ELISA - Q8NBP7

Monoclonal Antibodies

[KD Validated] Anti-PCSK9 (Proprotein Convertase 9) Monoclonal Antibody for WB, ELISA - Q8NBP7

Item Number : CM0003312

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human
Protein Weight
74kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name [KD Validated] Proprotein Convertase 9(PCSK9) Rabbit mAb
Remarks/Alias FH3; PC9; FHCL3; NARC1; LDLCQ1; NARC-1; HCHOLA3; [KD Validated] Proprotein Convertase 9(PCSK9)
Species Human
GeneID (human) 255738
GeneID 255738
Immunogen Synthetic peptide corresponding to a sequence within amino acids 593-692 of human PCSK9 (NP_777596.2)
Source Rabbit
Category Monoclonal Antibodies
Application WB, ELISA
Cross Reactivity Human
SWISS Q8NBP7
Protein Weight 74kDa
Shipping Ice bag

Biological Background: PCSK9 Function and Localization

  • Crucial regulator of plasma cholesterol homeostasis; binds to LDL receptor family members (LDLR, VLDLR, LRP1/APOER, LRP8/APOER2) and promotes their degradation in intracellular acidic compartments, preventing LDLR recycling. Related references: PMID:18039658 PMID:17461796 PMID:18197702 PMID:18799458
  • Acts via a non-proteolytic, clathrin-mediated pathway; induces ubiquitination of LDLR leading to lysosomal degradation.
  • Involved in disposal of non-acetylated BACE1 intermediates in the early secretory pathway. Related references: PMID:18660751
  • Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway; regulates ENaC-mediated Na⁺ absorption and neuronal apoptosis through LRP8/APOER2 modulation.
  • Subcellular localization includes cytoplasm, secreted, endosome, lysosome, cell surface, endoplasmic reticulum, and Golgi apparatus.
  • Post-translational modifications: glycoprotein, disulfide bonds, phosphoprotein, sulfation, autocatalytic cleavage from zymogen.
  • Tissue specificity: expressed in neuro-epithelioma, colon carcinoma, hepatic and pancreatic cell lines, and Schwann cells.

Experimental Guidance and Technical Tips

  • For western blot, expect a major band near 74 kDa (full-length precursor); autocatalytic cleavage may produce smaller fragments. Validate under reducing/non-reducing conditions in your sample system.
  • The immunogen corresponds to the C-terminal region (aa 593–692); ensure epitope accessibility in denaturing vs. native conditions.
  • For ELISA, consider testing antibody pair compatibility; steric hindrance with other clones may affect sensitivity.
  • Cross-reactivity confirmed for human; verify for other species if needed.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers and researchers with reliable access to validated IVD raw materials, including monoclonal antibodies, recombinant proteins, and bulk ancillary reagents. For PCSK9-related research in cholesterol metabolism and cardiovascular disease, CamelBio offers a comprehensive portfolio of validated antibody pairs, optimized clones, and rare target sourcing services, streamlining your development from concept to clinic.

View more faqs for this product

Product Datasheet

[KD Validated] Anti-PCSK9 (Proprotein Convertase 9) Monoclonal Antibody for WB, ELISA - Q8NBP7


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!